<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To validate the performance of current <z:mp ids='MP_0002055'>diabetes</z:mp> risk scores (DRSs) based on simple clinical information in detecting type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (MetSyn), and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">kidney disease</z:e> (CKD) </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: The performance of 10 DRSs was evaluated in a cross-sectional population screening of 2,759 Taiwanese subjects </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> DRSs significantly correlated with measures of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, estimated glomerular filtration rate, and urine albumin excretion </plain></SENT>
<SENT sid="3" pm="."><plain>The prevalence of screening-detected <z:mp ids='MP_0002055'>diabetes</z:mp> (SDM), MetSyn, and CKD increased with higher DRSs </plain></SENT>
<SENT sid="4" pm="."><plain>For prediction of SDM, the Cambridge DRS by Griffin et al. and the Finnish DRS outperformed other DRSs in terms of discriminative power and model fit </plain></SENT>
<SENT sid="5" pm="."><plain>For prediction of MetSyn and CKD, the <z:hpo ids='HP_0002621'>Atherosclerosis</z:hpo> Risk in Community Study score by <z:e sem="disease" ids="C0085860" disease_type="Disease or Syndrome" abbrv="">Schmidt</z:e> et al. outperformed other DRSs </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Risk scores based on simple clinical information are useful to identify individuals at high risk for <z:mp ids='MP_0002055'>diabetes</z:mp>, MetSyn, and CKD in different ethnic populations </plain></SENT>
</text></document>